A Future Unicorn company +41 44 508 70 77

+41 44 508 70 77

How can we help?

For patients

Oncompass Medicine

Introduction
Awards
Contact

For physicians

Contact us!

For patient safety, we also provide online and in-person consultation for patients and their relatives.

Apply for consultation Request a call-back

Call Us

+41 44 508 70 77

Send us an e-mail

info@oncompassmedicine.com

Oncompass in social media

Oncompass Gmbh.

Einsiedlerstrasse 21, 8834 Schindellegi, Switzerland

Scientific publications

Screenshot 2022 05 18 At 1347 53

March 12. 2024

A recent study explored the effectiveness of Digital Drug Assignment (DDA)

September 12. 2023

Euformatics, Oncompass Medicine and Institut Curie awarded Eurostars funding to develop an oncology solution with genomic noise canceling

Screenshot 2022 05 18 At 1347 53

December 1. 2022

Partnership of BC Platforms, Euformatics, and Oncompass Medicine, Selected to Deliver Standardized Oncology NGS Workflows for Seven Major European Hospitals

Screenshot 2022 05 18 At 1347 53

May 18. 2022

BC Platforms, Euformatics and Oncompass Medicine form a partnership to develop oncology NGS workflows for buyer consortium of seven major European hospitals

Labor1 1

April 21. 2022

A Hungarian participant will also attend the Washington summit on artificial intelligence

Cancer Services Big

February 4. 2022

Fight against cancer: 40% of the European population could soon be affected

January 6. 2022

Lasting Complete Clinical Response of a Recurring Cutaneous Squamous Cell Carcinoma With MEK Mutation and PIK3CA Amplification Achieved by Dual Trametinib and Metformin Therapy

October 7. 2021

Personalized First-Line Treatment of Metastatic Pancreatic Neuroendocrine Carcinoma Facilitated by Liquid Biopsy and Computational Decision Support

41698 2021 191 Fig1 Html

June 23. 2021

A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial

April 14. 2021

Combining immunotherapy with an epidrug in squamous cell carcinomas of different locations: rationale and design of the PEVO basket trial

September 17. 2020

Major Clinical Response to Afatinib Monotherapy in Lung Adenocarcinoma Harboring EGFR Exon 20 Insertion Mutation

August 28. 2020

Efficacy of Incremental Next-Generation ALK Inhibitor Treatment in Oncogene-Addicted, ALK-Positive, TP53-Mutant NSCLC

Get in the Ring

2021 Read more

Future Unicorn Award

2021 Read more

Asco Breakthrough

ASCO Breakthrough Innovations in Oncology

2019 Read more

Get in the Ring! V4

2019 Read more

More

About us

Our story

2003— —2024

Oncompass Medicine is a Hungarian medical enterprise dealing with the development of decision support and diagnostic medical devices that help the personalized treatment of cancer patients.

More information

//